what are the downsides of glp 1 GLP-1 receptor agonists The promise and peril of

slower dose titration and dietary modifications can reduce severity and duration

Despite metformins ability to lower glucose levels by boosting GLP-1 secretion in living organisms, it did not have the same effect on GLP-1 secretion in L cells during laboratory experiments (Mulherin et al., 2011)

Evidence of benefit is lacking for long-term weight loss with some data supporting weight gain and heart disease risks.It is stable under heat and over a broad range of pH conditions

Aging Cell 10 , 96102 (2011)

Its non-selectivity, considered a clinical drawback, is a scientific advantage: it allows for the isolation of the relative contributions of each MCR subtype using selective antagonism protocols (HS024, JNJ-10229570, MCL-0129)